The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Antiviral Drug-Induced Nephrotoxicity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341
Hospital-acquired renal insufficiency: A prospective study
Hou, S. H., Bushinsky, D. A., Wish, J. B., Cohen, J. J., & Harrington, J. T. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90618-6 · Cited by 1,238
Strauss, M. B., & Welt, L. G. (1963) · Little, Brown eBooks · Cited by 852
Schmidt, G. M., Horak, D. A., Niland, J. C., Duncan, S. R., Forman, S. J., Zaia, J. A., & the City of Hope–Stanford–Syntex CMV Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199104113241501 · Cited by 616
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
Schuetz, J. D., Connelly, M. C., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., Kumar, A., & Fridland, A. (1999) · Nature Medicine · doi:10.1038/12487 · Cited by 575
Nucleoside and nucleobase transport systems of mammalian cells
Griffith, D. A., & Jarvis, S. M. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00008-1 · Cited by 493
(1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260401 · Cited by 487
Wijnholds, J., Mol, C. A. A. M., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., De Clercq, E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120159197 · Cited by 478
Autoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid Tumors
Rönnblom, L. E., Alm, G. V., & Öberg, K. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-178 · Cited by 455
The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides
Jedlitschky, G., Burchell, B., & Keppler, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005463200 · Cited by 442
Birkus, G., Hitchcock, M. J. M., & Cihlar, T. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.716-723.2002 · Cited by 441
Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., Valk, M. V. D., Krimpenfort, P., & Borst, P. (1997) · Nature Medicine · doi:10.1038/nm1197-1275 · Cited by 432
Expression Cloning and Characterization of ROAT1
Sweet, D. H., Wolff, N. A., & Pritchard, J. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30088 · Cited by 428
Safrin, S., Crumpacker, C., Chatis, P., Davis, R., Hafner, R., Rush, J., Kessler, H. A., Landry, B., & Mills, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108223250805 · Cited by 375
Reid, G., Wielinga, P., Zelcer, N., de Haas, M., van Deemter, L., Wijnholds, J., Balzarini, J., & Borst, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1094 · Cited by 368
Karras, A., Lafaurie, M., Furco, A., Bourgarit, A., Droz, D., Sereni, D., Legendre, C., Martinez, F., & Molina, J. (2003) · Clinical Infectious Diseases · doi:10.1086/368314 · Cited by 361
HO, E. S., LIN, D. C., MENDEL, D. B., & CIHLAR, T. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113383 · Cited by 356
Fanconi syndrome and renal failure induced by tenofovir: A first case report
Verhelst, D., Monge, M., Meynard, J.-L., Fouqueray, B., Mougenot, B., Girard, P.-M., Ronco, P., & Rossert, J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36924 · Cited by 349
Cihlar, T., Lin, D. C., Pritchard, J. B., Fuller, M. D., Mendel, D. B., & Sweet, D. H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23084-4 · Cited by 345
Barditch-Crovo, P., Deeks, S. G., Collier, A., Safrin, S., Coakley, D. F., Miller, M., Kearney, B. P., Coleman, R. L., Lamy, P. D., Kahn, J. O., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2733-2739.2001 · Cited by 330
Crystalluria and Urinary Tract Abnormalities Associated with Indinavir
Kopp, J. B., Miller, K. D., Mican, J. A. M., Feuerstein, I. M., Vaughan, E., Baker, C., Pannell, L. K., & Falloon, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-2-199707150-00004 · Cited by 312
Schooley, R. T., Ruane, P., Myers, R. A., Beall, G., Lampiris, H., Berger, D., Chen, S.-S., Miller, M. D., Isaacson, E., & Cheng, A. K. (2002) · AIDS · doi:10.1097/00002030-200206140-00008 · Cited by 270
Lorico, A., Rappa, G., Finch, R. A., Yang, D. D., Flavell, R. A., & Sartorelli, A. C. (1997) · PubMed · Cited by 241
Drug-Induced Renal Failure: Update on New Medications and Unique Mechanisms of Nephrotoxicity
Perazella, M. A. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200306000-00006 · Cited by 225
Acyclovir-induced renal failure
Sawyer, M. H., Webb, D. E., Balow, J. E., & Straus, S. E. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90313-0 · Cited by 222
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
Ljungman, P. (2001) · Blood · doi:10.1182/blood.v97.2.388 · Cited by 220
Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletion
Tanji, N., Tanji, K., Kambham, N., Markowitz, G. S., Bell, A., & D'Agati, V. D. (2001) · Human Pathology · doi:10.1053/hupa.2001.25586 · Cited by 207
Wijnholds, J., Scheffer, G. L., van der Valk, M., van der Valk, P., Beijnen, J. H., Scheper, R. J., & Borst, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.797 · Cited by 202
Kahn, J. (1999) · JAMA · doi:10.1001/jama.282.24.2305 · Cited by 199
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients
Cundy, K. C., Petty, B. G., Flaherty, J., Fisher, P. E., Polis, M. A., Wachsman, M., Lietman, P. S., Lalezari, J. P., Hitchcock, M. J., & Jaffe, H. S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1247 · Cited by 199
Izzedine, H., Hulot, J. S., Vittecoq, D., Gallant, J. E., Staszewski, S., Launay-Vacher, V., Cheng, A., Deray, G., & for the Study 903 Team (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh658 · Cited by 182
Self-citationAverbuch, S. D., Austin, H. A., Sherwin, S. A., Antonovych, T., Bunn, P. A., & Longo, D. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401053100107 · Cited by 181
Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export Proteins
Gutmann, H., Fricker, G., Drewe, J., Toeroek, M., & Miller, D. S. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12649-1 · Cited by 180
(1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-4-199702150-00002 · Cited by 178
Renal safety of tenofovir in HIV treatment-experienced patients
Izzedine, H., Isnard-Bagnis, C., Hulot, J. S., Vittecoq, D., Cheng, A., Jais, C. K., Launay-Vacher, V., & Deray, G. (2004) · AIDS · doi:10.1097/00002030-200404300-00019 · Cited by 173
Self-citationRenal function after acyclovir intravenous injection
Brigden, D., Rosling, A. E., & Woods, N. C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90087-0 · Cited by 171
Izzedine, H., Hulot, J. S., Launay-Vacher, V., Marcellini, P., Hadziyannis, S. J., Currie, G., Brosgart, C. L., Westland, C., Arterbrun, S., & Deray, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00866.x · Cited by 159
Self-citationJacobson, M. A., O’Donnell, J. J., & MILLS, J. S. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.5.736 · Cited by 153
Lai, Y., Tse, C., & Unadkat, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307938200 · Cited by 149
Drug-Induced Thrombotic Microangiopathy: Incidence, Prevention and Management
Pisoni, R., Ruggenenti, P. L., & Remuzzi, G. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00002 · Cited by 140
Peng, K., Cluzeaud, F., Bens, M., Huyen, J. D. V., Wioland, M.-A., Lacave, R., & Vandewalle, A. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700605 · Cited by 137
Urinary stones in HIV-1-positive patients treated with indinavir
Daudon, M., Estepa, L., Viard, J., Joly, D. A., & Jungers, P. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62506-8 · Cited by 136
Rollot, F., Nazal, E.-M., Chauvelot‐Moachon, L., Kelaïdi, C., Daniel, N., Saba, M., Abad, S., & Blanche, P. (2003) · Clinical Infectious Diseases · doi:10.1086/379829 · Cited by 131
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole*
Moore, K. H. P., Yuen, G. J., Raasch, R. H., Eron, J. J., Martin, D., Mydlow, P. K., & Hussey, E. K. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90183-6 · Cited by 129
Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients
Cundy, K. C., Barditch‐Crovo, P., WALKER, R. E., Collier, A. C., Ebeling, D., Toole, J., & Jaffe, H. S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2401 · Cited by 129
Wada, S., Tsuda, M., Sekine, T., Ho, S., Kimura, M., Kanai, Y., & Endou, H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39144-x · Cited by 128
Crystalluria: a neglected aspect of urinary sediment analysis
Fogazzi, G. B. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027276 · Cited by 127
Glasg, M. B. (1975) · PubMed · Cited by 126
Cihlář, T., Birkuš, G., Greenwalt, D. E., & Hitchcock, M. J. M. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00210-8 · Cited by 123
Drug-Induced Diabetes Insipidus
Bendz, H., & Aurell, M. (1999) · Drug Safety · doi:10.2165/00002018-199921060-00002 · Cited by 120
Tashima, K. T., Horowitz, J. D., & Rosen, S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360215 · Cited by 120
Adverse Effects of High-Dose Intravenous Acyclovir in Ambulatory Patients with Acute Herpes Zoster
Bean, B., & Aeppli, D. M. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.2.362 · Cited by 118
Chugh, S. S., Bird, R., & ALEXANDER, E. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360214 · Cited by 113
Lalezari, J. P., Holland, G. N., Kramer, F., McKinley, G. F., Kemper, C. A., Ives, D. V., Nelson, R. P., Hardy, W. D., Kuppermann, B. D., Northfelt, D., et al. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199804010-00008 · Cited by 113
Keeney, R. E., Kirk, L. E., & Bridgen, D. T. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90086-9 · Cited by 106
Fisher, E. J., Chaloner, K. M., Cohn, D. L., Grant, L. B., Alston, B., Brosgart, C. L., Schmetter, B., El-Sadr, W. M., & Sampson, J. H. (2001) · AIDS · doi:10.1097/00002030-200109070-00013 · Cited by 95
Ganapathy, M. E., Prasad, P. D., Mackenzie, B., Ganapathy, V., & Leibach, F. H. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(96)00234-9 · Cited by 93
Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.
Berns, J. S., Cohen, R. M., Stumacher, R. J., & Rudnick, M. R. (1991) · Journal of the American Society of Nephrology · doi:10.1681/asn.v191061 · Cited by 79
Cyclooxygenase-2 expression and function in the medullary thick ascending limb.
Ferreri, N., An, S., & Mcgiff, J. (1999) · AJP - Renal Physiology · doi:10.1152/ajprenal.1999.277.3.f360 · Cited by 78
Acute renal failure due to indinavir crystalluria and nephrolithiasis: Report of two cases
Berns, J. S., Cohen, R. M., Silverman, M. E., & Turner, J. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90316-4 · Cited by 75
Safety of pamidronate in patients with renal failure and hypercalcemia.
Machado, C., & Flombaum, C. D. (1996) · PubMed · Cited by 73
Acyclovir Neurotoxicity and Nephrotoxicity-The Role for Hemodialysis
Bf, K., Rudy, D. W., Glick, M. R., & Clayman, M. D. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199301000-00007 · Cited by 63
Gallant, J. E., Staszewski, S., Pozniak, A., DeJesus, E., Suleiman, J. M. A. H., Miller, M. D., Coakley, D. F., Lu, B., Toole, J. J., & Cheng, A. (2004) · Cited by 62
Renal Atrophy Associated with Long-Term Treatment with Indinavir
Hanabusa, H., Tagami, H., & Hataya, H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400515 · Cited by 59
Acute Renal Failure and Coma after a High Dose of Oral Acyclovir
Eck, P., Sm, S., & Clark, E. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251617 · Cited by 59
Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy
Navarro‐González, J. F., Quereda, C., Quereda, C., Gallego, N., Antela, A., Mora, C., & Ortuño, J. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90369-8 · Cited by 53
Electrolyte and acid-base disorders associated with AIDS
Perazella, M. A., & Brown, E. (1994) · Journal of General Internal Medicine · doi:10.1007/bf02600132 · Cited by 52
Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART
Berger, E. A., Moss, B., & Pastan, I. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11511 · Cited by 51
Traynor, A. E., Kuzel, T. M., Samuelson, E., & Kanwar, Y. S. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187894 · Cited by 49
Renal transport of organic anions
Roch‐Ramel, F. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199809000-00006 · Cited by 47
Indinavir nephropathy revisited: A pattern of insidious renal failure with identifiable risk factors
Reilly, R. F., Tray, K., & Perazella, M. A. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27732 · Cited by 46
Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria.
Perazella, M. A., Kashgarian, M. J., & Cooney, E. L. (1998) · PubMed · Cited by 43
Identification of crystals in kidneys of AIDS patients treated with foscarnet
Estepa, L., Daudon, M., Katlama, C., Jouanneau, C., Sazdovitch, V., Lacour, B., & Beaufils, H. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9740154 · Cited by 41
Severe Hypertension and Renal Atrophy Associated with Indinavir
Cattelan, A. M., Trevenzoli, M., Naso, A., Meneghetti, F., & Cadrobbi, P. (2000) · Clinical Infectious Diseases · doi:10.1086/313728 · Cited by 37
Turriziani, O., Schuetz, J. D., Focher, F., Scagnolari, C., Sampath, J., Adachi, M., Bambacioni, F., Riva, E., & Antonelli, G. (2002) · Biochemical Journal · doi:10.1042/bj20020494 · Cited by 34
Low-Dose Acyclovir and Acute Renal Failure
GIUSTINA, A., ROMANELLI, G., CIMINO, A., & BRUNORI, G. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-312_1 · Cited by 32
Indinavir Nephrolithiasis in Warm Climates
Bach, M. C., & Godofsky, E. W. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199703010-00017 · Cited by 30
Renal Dysfunction in a Human Immunodeficiency Virus–Infected Patient Who Was Treated with Indinavir
Grünke, M., Valerius, T., Manger, B., Kalden, J. R., & Harrer, T. (1997) · Clinical Infectious Diseases · doi:10.1086/516978 · Cited by 21
Nephrogenic diabetes insipidus in a patient taking cidofovir
Schliefer, K., Rockstroh, J. K., Spengler, U., & Sauerbruch, T. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64137-2 · Cited by 19
Lechner, J., & Pfaller, W. (2001) · Renal Failure · doi:10.1081/jdi-100104739 · Cited by 14
Latrogenic nephrogenic diabetes insipidus
Singh, G. (2003) · AIDS · doi:10.1097/00002030-200306130-00030 · Cited by 6
Cited by
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
Renal Vulnerability to Drug Toxicity
Perazella, M. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02050309 · Cited by 403
An overview of drug-induced acute kidney injury
Pannu, N., & Nadim, M. K. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318168e375 · Cited by 352
Drug-associated renal dysfunction and injury
Choudhury, D., & Ahmed, Z. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0076 · Cited by 345
Mechanism of Active Renal Tubular Efflux of Tenofovir
Ray, A. S., Cihlar, T., Robinson, K. L., Tong, L., Vela, J. E., Fuller, M. D., Wieman, L. M., Eisenberg, E. J., & Rhodes, G. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00251-06 · Cited by 323
Metadata
- Authors
- Izzedine, H., Launay-Vacher, V., & Deray, G.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 45
- Issue
- 5
- Pages
- 804-817
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2117134953
- Cited by
- 423
- References
- 82
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.